O'Keefe Stevens Advisory, Inc. Amgen Inc Transaction History

O'Keefe Stevens Advisory, Inc.

$305 Million
Q3 2024

A detailed history of O'Keefe Stevens Advisory, Inc. transactions in Amgen Inc stock. As of the latest transaction made, O'Keefe Stevens Advisory, Inc. holds 47,551 shares of AMGN stock, worth $12.6 Million. This represents 5.02% of its overall portfolio holdings.

Number of Shares

47,551

Previous 47,642 0.19%

Holding current value

$12.6 Million

Previous $14.9 Million 2.93%

% of portfolio

5.02%

Previous 5.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$309.38 - $337.38 $28,153 - $30,701	-91 Reduced 0.19%	47,551 $15.3 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $195,748 - $237,885	-745 Reduced 1.54%	47,642 $14.9 Million
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $11,292 - $13,631	42 Added 0.09%	48,387 $13.8 Million
Q4 2023 Jan 05, 2024	SELL	$255.7 - $288.46 $32,985 - $37,211	-129 Reduced 0.27%	48,345 $13.9 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $124,849 - $155,003	571 Added 1.19%	48,474 $13 Million
Q2 2023 Jul 06, 2023	BUY	$214.27 - $253.37 $234,625 - $277,440	1,095 Added 2.34%	47,903 $10.6 Million
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $55,544 - $67,699	-246 Reduced 0.52%	46,808 $11.3 Million
Q4 2022 Jan 10, 2023	BUY	$229.03 - $291.01 $1,374 - $1,746	6 Added 0.01%	47,054 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $84,396 - $95,184	376 Added 0.81%	47,048 $10.6 Million
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $6,690 - $7,445	29 Added 0.06%	46,672 $11.4 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $250,187 - $276,772	1,141 Added 2.51%	46,643 $11.3 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $158,507 - $181,397	797 Added 1.78%	45,502 $10.2 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $85,120 - $99,728	-401 Reduced 0.89%	44,705 $9.51 Million
Q2 2021 Jul 12, 2021	BUY	$233.58 - $259.14 $134,308 - $149,005	575 Added 1.29%	45,106 $11 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $22,191 - $25,860	100 Added 0.23%	44,531 $11 Million
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $227,848 - $271,326	-1,053 Reduced 2.32%	44,431 $10.2 Million
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $100,899 - $112,208	-430 Reduced 0.94%	45,484 $11.6 Million
Q2 2020 Jul 08, 2020	SELL	$197.81 - $242.74 $104,245 - $127,923	-527 Reduced 1.13%	45,914 $10.8 Million
Q4 2019 Jan 07, 2020	BUY	$189.21 - $243.2 $946 - $1,216	5 Added 0.01%	46,441 $11.2 Million
Q4 2019 Jan 06, 2020	SELL	$189.21 - $243.2 $128,662 - $165,376	-680 Reduced 1.44%	46,436 $11.2 Million
Q3 2019 Oct 07, 2019	BUY	$174.11 - $208.62 $36,911 - $44,227	212 Added 0.45%	47,116 $9.12 Million
Q2 2019 Jul 08, 2019	BUY	$166.7 - $195.41 $109,688 - $128,579	658 Added 1.42%	46,904 $8.64 Million
Q1 2019 Jul 08, 2019	BUY	$180.87 - $203.88 $53,356 - $60,144	295 Added 0.64%	46,246 $8.79 Million
Q4 2018 Jul 08, 2019	SELL	$178.4 - $208.25 $95,087 - $110,997	-533 Reduced 1.15%	45,951 $8.95 Million
Q3 2018 Jul 08, 2019	SELL	$185.29 - $208.89 $3,149 - $3,551	-17 Reduced 0.04%	46,484 $9.64 Million
Q2 2018 Jul 08, 2019	BUY	$166.05 - $186.51 $3.88 Million - $4.36 Million	23,380 Added 101.12%	46,501 $8.58 Million
Q1 2018 Jul 08, 2019	BUY	$169.43 - $198.0 $271,596 - $317,394	1,603 Added 7.45%	23,121 $3.94 Million
Q4 2017 Jul 08, 2019	BUY	$168.79 - $188.59 $166,258 - $185,761	985 Added 4.8%	21,518 $3.74 Million
Q3 2017 Jul 08, 2019	BUY	$167.29 - $191.0 $3.43 Million - $3.92 Million	20,533	20,533 $3.83 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Keefe Stevens Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on O'Keefe Stevens Advisory, Inc. with notifications on news.

Account

O'Keefe Stevens Advisory, Inc. Amgen Inc Transaction History